title: Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy.
authors.affiliation: Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, 70 E 66th St, New York, NY 10065, USA. abramsod@mskcc.org
authors.forename: David H
authors.initials: DH
authors.lastname: Abramson
authors.forename: Ira J
authors.initials: IJ
authors.lastname: Dunkel
authors.forename: Scott E
authors.initials: SE
authors.lastname: Brodie
authors.forename: Brian
authors.initials: B
authors.lastname: Marr
authors.forename: Y Pierre
authors.initials: YP
authors.lastname: Gobin
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002408:Catheters, Indwelling; D004596:Electroretinography; D005074:Evoked Potentials, Visual; D005260:Female; D005500:Follow-Up Studies; D007839:Functional Laterality; D006801:Humans; D007223:Infant; D007261:Infusions, Intra-Arterial; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D009880:Ophthalmic Artery; D012160:Retina / Q000502:physiology; D019572:Retinal Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D012175:Retinoblastoma / Q000188:drug therapy* / Q000503:physiopathology; D019772:Topotecan / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D019772:Topotecan; D008558:Melphalan